Missoni crashes Target.com
MINNEAPOLIS — Target’s just-released Missoni collection resonated so well with consumers that the demand for the line lead to the crashing of Target’s website on Tuesday. Various newspapers reported that the collection was flying off the shelves of stores, and that some stores were sold out within minutes.
Target posted a note on its website: "Woof! We are suddenly extremely popular. You may not be able to access our site momentarily due to unusually high traffic. Please stay here and we’ll try to get you in as soon as we can!"
Understanding the likely frustration of thousands of shoppers looking to get their hands on some Missoni gear, the chain also apologized via Twitter: "Apologies to #Target shoppers mad for #MissoniforTarget — we’re working on getting Target.com back up!"
Target previewed the new collection last week with a pop-up store in midtown Manhattan during Fashion’s Night Out event. The retailer had to shut down the store a day ahead of schedule when it ran out of inventory.
Citigroup retail analyst Deb Weinswig endured a two-and-a-half-hour wait in line for an opportunity to preview the line.
“The wait was worth it, as Missoni for Target represents Target’s largest designer partnership to date,” Weinswig said. “We expect the Missoni collection to surpass the Liberty of London line from Spring 2010, as Missoni for Target includes more than 400 items spanning multiple product categories including apparel for women, men, and kids, accessories, shoes, baby, beauty and home.”
Ahold names new finance chief
AMSTERDAM — Ahold has announced the appointment of Jeff Carr as EVP and CFO, starting Nov. 12.
Carr will be a member of Ahold’s corporate executive board, pending shareholder approval. He will succeed Kimberly Ross, who is leaving Ahold in November to become CFO of Avon.
Carr will be responsible for Ahold’s finance, real estate and IT functions. He will also manage the company’s existing €350 million cost reduction program and explore further ways to reduce costs and simplify the business.
"We are delighted to have an experienced finance professional of Jeff’s caliber joining our board," Ahold CEO Dick Boer said. "He has an impressive track record and broad experience in the consumer goods and services industry on both of the continents where Ahold operates. Jeff has been CFO of listed companies since 2005, and has worked and lived in Europe and the United States. His background and expertise in finance will help us to pursue our growth strategy," Boer said.
Carr, 49, is a British national. He currently is group finance director and a member of the board at U.K.-based FirstGroup, the leading transport operator in the United Kingdom and North America, including Greyhound in the United States and Canada. Before joining FirstGroup, he was group finance director and board member at EasyJet, and held senior financial roles at Associated British Foods, Reckitt Benckiser, and Grand Metropolitan. He began his career at Unilever.
Study: Antimicrobial-resistant MRSA revealed; may reverse infection decline
ATLANTA — A new resistant strain of methicillin-resistant staphylococcus aureus may be on the rise due to the frequent use of over-the-counter antibacterial ointments, according to a study to be published in the October issue of Emerging Infectious Diseases.
As reported by CNN.com, Japanese researchers made the finding after testing 259 MRSA strains for susceptibility to bacitracin and neomycin, two of the antibacterial ingredients commonly found in such OTC ointments as Neosporin and Polysporin.
According to the report, resistance to bacitracin and neomycin was only found in USA300, a type of MRSA found in the United States. Because triple-antibiotic ointments are widely used in the United States, and rarely outside of the U.S., researchers determined that there may be a link.
The USA300 strain of MRSA still can be treated with vancomycin and other drugs, the report noted, but doctors in the United States should be aware the ointment therapy may not be effective in USA300 infections.
Before this report, all indicators have pointed to the decline of MRSA infections. In 2010, a Centers for Disease Control and Prevention study published in the Journal of the American Medical Association showed that invasive (life-threatening) MRSA infections in healthcare settings declined 28% from 2005 through 2008. In addition, the study showed a 17% drop in invasive MRSA infections that were diagnosed before hospital admissions in people with recent exposures to healthcare settings.
That study complemented data from the National Healthcare Safety Network that found rates of MRSA bloodstream infections occurring in hospitalized patients fell nearly 50% from 1997 to 2007.
"Taken together and with other reports such as the March 2011 ‘CDC Vital Signs’ article, these studies provide evidence that rates of invasive MRSA infections in the United States are falling," the CDC noted on its MRSA website. "While MRSA remains an important public health problem and more remains to be done to further decrease risks of developing these infections, this decrease in healthcare-associated MRSA infections is encouraging."